Our goal is to complement the current strategic interest of Chiesi Farmaceutici in the space of rare diseases by investing in early
stage opportunities and accelerate the
expansion of the Chiesi network in the US among universities,
venture capital investors, rare disease patient organizations and start - ups developing treatments for rare diseases.
BDC
Venture Capital is a major venture capital investor in Canada, active at every stage of the company's development cycle, from seed through expansion, with a focus on innovative technology - based Canadian companies that have high growth potential, offer unique products or services and that are positioned to become dominant players in their m
Venture Capital is a major
venture capital investor in Canada, active at every stage of the company's development cycle, from seed through expansion, with a focus on innovative technology - based Canadian companies that have high growth potential, offer unique products or services and that are positioned to become dominant players in their m
venture capital investor in Canada, active at every
stage of the company's development cycle, from seed through
expansion, with a focus on innovative technology - based Canadian companies that have high growth potential, offer unique products or services and that are positioned to become dominant players in their markets.